INDICATION: Ovarian cancer
Mouse studies suggest nanoparticles loaded with an ADORA2A antagonist and conjugated to CAR T cells could help treat ovarian cancer. The
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury